Skip to Content

Stroke Program Clinical Trials

Non-blinded Data Collection Pilot Study of Acute Stroke Using the BRAINPULSE™
Aims: The purpose of this pilot study is to collect data from patients experiencing stroke using the BrainPulse device.  In the 2nd (current) phase of the study, data will be collected on two groups of patients: Those with Large Vessel Occlusion (LVO) acute stroke and non-LVO acute stroke. The data collected from the BrainPulse will be compared across these study groups in an attempt to distinguish stroke from other non-stroke conditions that present with similar symptoms and LVO from non-LVO types of strokes. Further assessments will also be made to evaluate if the BrainPulse can identify the presence of stroke.
Principal Investigator: Shakeel Chowdhry, MD
NorthShore Project Number: EH19-084
Contact: Call 847.570.4224 with questions regarding the study
Open to enrollment: Yes

ENRICH: Early Minimally-Invasive Removal of ICH
Aims:
The purpose of this study is to provide clinical evidence of functional improvement, safety, and economic benefit when comparing intracerebral hemorrhage (ICH) evacuation (removal of a blood clot from the brain using the minimally invasive BrainPath access system), to medical treatment.
Principal Investigator: Shakeel Chowdhry, MD
NorthShore Project Number: EH17-038
Contact: Call 847.570.4224 with questions regarding the study
Open to enrollment: Yes

Automated Detection, Characterization, Triage, and Recruitment of ICH Subjects Using Artificial Intelligence in the ENRICH Trial
Aims: The purpose of the Viz.ai trial is to evaluate the performance of Viz.ai software in its ability to increase enrollment of subjects evaluated for intracranial hemorrhage (ICH) via CT imaging into the ENRICH study (NorthShore Study # EH17-038).  Viz.ai will automatically analyze CT scans to identify and calculate the volume of suspected ICH. If ICH is present, a notification will be sent to the Principal Investigator of the study. Viz.ai will also evaluate ICH parameters against the ENRICH Trial inclusion and exclusion criteria. If an enrolled subject is ultimately included in the ENRICH trial, the subject will be identified in a prospective cohort of subjects exposed to Viz.ai (intervention arm) and will be evaluated per the secondary endpoints to subjects previously enrolled and not exposed to Viz.ai (control arm).
Principal Investigator: Shakeel Chowdhry, MD
NorthShore Project Number: EH19-253
Contact: Call 847.570.4224 with questions regarding the study